# OnCo record hypercalcaemia-of-malignancy-management (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/hypercalcaemia-of-malignancy-management/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "hypercalcaemia-of-malignancy-management" ;
  schema:name "Hypercalcaemia of malignancy: assessment, intravenous fluids, bisphosphonate or denosumab"@en ;
  schema:alternateName "malignant hypercalcaemia"@en, "hypercalcemia of malignancy treatment"@en, "HCM"@en, "high calcium in cancer"@en, "cancer-related hypercalcaemia"@en ;
  schema:description "Some cancers raise the calcium level in the blood. It causes thirst, passing a lot of urine, constipation, sickness, tiredness and confusion, and can be dangerous. A blood test confirms it. Treatment is a drip of fluid, then a medicine that stops calcium leaving the bones (a bisphosphonate such as zoledronic acid, or denosumab), alongside treatment of the cancer itself."@en ;
  schema:url <https://onco.cc/protocols/hypercalcaemia-of-malignancy-management/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "acute-oncology", "oncological-emergency", "metabolic" ;
  onco:drugs <https://onco.cc/drugs/zoledronic-acid/>, <https://onco.cc/drugs/pamidronate/>, <https://onco.cc/drugs/ibandronic-acid/>, <https://onco.cc/drugs/denosumab/>, <https://onco.cc/drugs/cinacalcet/> ;
  onco:terms <https://onco.cc/terms/bone-metastases/> .